News

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...
A DAD once nicknamed “Fat Pal” by his friends has dropped five stone in five months after using Mounjaro. Sean Burns, 32, from Glasgow, said he has “struggled with excess weight” his whole life ...
In his first book, Dr Jack Mosley warns weight-loss drugs can be dangerous - and continues his father's championing of ...
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...
CHRISTINA Park had struggled with yo-yo dieting for years – trapped in a vicious cycle of losing 4 to 8lb, then putting on 6 ...
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...
Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...
Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.